TEARDOWN 01 · BAYKAR · $2.5B
The boring decade is the balance sheet.
Before it became a $2.5B global leader, Baykar spent roughly sixteen years as an ordinary auto-parts machine shop. That wasted decade is the whole story: it generated the cash and the manufacturing depth that later funded an unproven moonshot — with zero outside capital, so no investor could ever vote the founders out of it.
Takeaway
The boring years aren't a detour. They're the balance sheet that buys you the right to do something audacious later — entirely on your own terms.
TEARDOWN 02 · HELSING · EUR 12B
Sell the thesis before the product.
Helsing raised 100M euros with no product — on a single sentence: defense is a software problem wearing a hardware costume. A clean, contrarian thesis, stated as a category instead of a product, lets you raise on a vision before revenue exists. Helsing rode it to a 12B euro valuation, then used the war chest to buy the very hardware it had promised to avoid.
Takeaway
State your thesis as a category, not a product. Raise on it. Then go build what the thesis earns you the right to buy.
TEARDOWN 03 · ANDURIL · $61B
Self-fund the R&D the customer used to pay for.
For seventy years defense ran on cost-plus: the government funds your research, you bill cost plus a margin, and your incentive is to spend more, not ship faster. Anduril pays for its own development and hands the customer a fixed price instead — and calls itself a products company, not a contractor. Most of why a nine-year-old company is worth $61B sits in that one financing choice.
Takeaway
Whoever funds the R&D owns the roadmap, the IP, and the margin. The financing choice is the strategy.
